Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5975)
All Articles published online
|
Publishing Process of This Article
|
Dec 27, 2013 (publication date) through Nov 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Licata A, Maida M, Bonaccorso A, Macaluso FS, Cappello M, Craxì A, Almasio PL. Clinical course and prognostic factors of hepatorenal syndrome: A retrospective single-center cohort study. World J Hepatol 2013; 5(12): 685-691 [PMID: 24432185 DOI: 10.4254/wjh.v5.i12.685] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v5/i12/685.htm |
| Number | Citing Articles |
| 1 |
Wenhan Fan, Wei Liao, Shengjun Jiang, Yi Chen, Chengzhong Li, Xuesong Liang. Development of novel prognostic models based on dynamic changes in risk factors for hepatitis B associated acute-on-chronic liver failure:a 10-year retrospective study. Heliyon 2024; 10(7): e29276 doi: 10.1016/j.heliyon.2024.e29276
|
| 2 |
Natasha Shah, Rogelio G. Silva, Andrew Kowalski, Chaitanya Desai, Edgar Lerma. Hepatorenal syndrome. Disease-a-Month 2016; 62(10): 364 doi: 10.1016/j.disamonth.2016.05.009
|
| 3 |
Jagmeet Singh, Dushyant Singh Dahiya, Asim Kichloo, Gurdeep Singh, Katayoun Khoshbin, Hafeez Shaka. Hepatorenal syndrome: a Nationwide Trend Analysis from 2008 to 2018. Annals of Medicine 2021; 53(1): 2018 doi: 10.1080/07853890.2021.1998595
|
| 4 |
Kazuya Okushin, Hayato Yamana, Ryosuke Tateishi, Masaya Sato, Takeya Tsutsumi, Hiroki Matsui, Kiyohide Fushimi, Hideo Yasunaga, Kazuhiko Koike, Mitsuhiro Fujishiro. Treatment and outcome of hepatorenal syndrome in Japan: a retrospective cohort study using a national inpatient database. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02858-5
|
| 5 |
Shuan Zhang, Ling-Ling He, Xin-Hui Wang, Zhi-Bo Dang, Xiao-Li Liu, Meng-Ge Li, Xian-Bo Wang, Zhi-Yun Yang. A novel scoring model for predicting mortality risk in patients with cirrhosis and hepatorenal syndrome. European Journal of Gastroenterology & Hepatology 2018; 30(8): 938 doi: 10.1097/MEG.0000000000001127
|
| 6 |
Isabelle Colle, Pierre-François Laterre. Hepatorenal syndrome: the clinical impact of vasoactive therapy. Expert Review of Gastroenterology & Hepatology 2018; 12(2): 173 doi: 10.1080/17474124.2018.1417034
|
| 7 |
Andrew J. Muir. Understanding the Complexities of Cirrhosis. Clinical Therapeutics 2015; 37(8): 1822 doi: 10.1016/j.clinthera.2015.05.507
|
| 8 |
Alana Zulian Terres, Rafael Sartori Balbinot, Ana Laura Facco Muscope, Morgana Luisa Longen, Bruna Schena, Bruna Teston Cini, Gilberto Luis Rost, Juline Isabel Leichtweis Balensiefer, Louise Zanotto Eberhardt, Raul Angelo Balbinot, Silvana Sartori Balbinot, Jonathan Soldera. Predicting mortality for hepatorenal syndrome with liver‐specific scores. GastroHep 2020; 2(6): 336 doi: 10.1002/ygh2.429
|
| 9 |
M. L. Katsin, M. Y. Hurava, Pavel S. Prylutski, A. M. Dzyadz’ko, O. O. Rummo. Pathogenesis and clinical significance of the hyperdynamic circulatory syndrome in liver cirrhosis. Review. Annals of Critical Care 2021; (1): 123 doi: 10.21320/1818-474X-2021-1-123-133
|
| 10 |
Jan Heidemann, Christoph Bartels, Christoph Berssenbrügge, Hartmut Schmidt, Tobias Meister. Hepatorenal Syndrome: Outcome of Response to Therapy and Predictors of Survival. Gastroenterology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/457613
|
| 11 |
Yi Song, Yu Wang, Chaoran Zang, Xiaoxi Yang, Zhenkun Li, Lina Wu, Kang Li. Prognostic Nomograms for Hospital Survival and Transplant-Free Survival of Patients with Hepatorenal Syndrome: A Retrospective Cohort Study. Diagnostics 2022; 12(6): 1417 doi: 10.3390/diagnostics12061417
|
| 12 |
Influence of Biologically Active Substance “STEMB” on a Morphofunctional Condition of a Liver and Kidneys of Rats at an Experimental Hepatorenal Syndrome. Journal of Pharmacy and Nutrition Sciences 2015; 5(3): 186 doi: 10.6000/1927-5951.2015.05.03.3
|
| 13 |
Fred F. Poordad. Presentation and complications associated with cirrhosis of the liver. Current Medical Research and Opinion 2015; 31(5): 925 doi: 10.1185/03007995.2015.1021905
|
| 14 |
Margarita Rey R., Andrés F. Delgado, Alejandra De Zubiria, Renzo Pinto, José A. De la Hoz-Valle, Erika D. Pérez-Riveros, Gerardo Ardila, Fernando Sierra-Arango, Sevtap Savas. Prevalence and short-term outcome of hepatorenal syndrome: A 9-year experience in a high-complexity hospital in Colombia. PLOS ONE 2020; 15(10): e0239834 doi: 10.1371/journal.pone.0239834
|
| 15 |
Antonio Gabriel D Corona, Holly M Koncicki. The intersection of oncology, nephrology, and palliative care. Journal of Onco-Nephrology 2021; 5(1): 48 doi: 10.1177/23993693211001380
|
| 16 |
Hsuan Yeh, Chun-Cheng Chiang, Tzung-Hai Yen. Hepatocellular carcinoma in patients with renal dysfunction: Pathophysiology, prognosis, and treatment challenges. World Journal of Gastroenterology 2021; 27(26): 4104-4142 doi: 10.3748/wjg.v27.i26.4104
|
| 17 |
Anna Licata, Alessandra Mazzola, Daniela Ingrassia, Vincenza Calvaruso, Calogero Cammà, Antonio Craxì. Clinical implications of the hyperdynamic syndrome in cirrhosis. European Journal of Internal Medicine 2014; 25(9): 795 doi: 10.1016/j.ejim.2014.09.004
|
| 18 |
Juan G Acevedo, Matthew E Cramp. Hepatorenal syndrome: Update on diagnosis and therapy. World Journal of Hepatology 2017; 9(6): 293-299 doi: 10.4254/wjh.v9.i6.293
|
| 19 |
Umer Farooq, Zahid Ijaz Tarar, Abdallah El Alayli, Faisal Kamal, Chengu Niu, Kamran Qureshi. Analyzing the utility of renal replacement therapy to manage hepatorenal syndrome in alcoholic hepatitis without liver transplantation: a nationwide analysis. Journal of Gastroenterology and Hepatology 2024; 39(3): 560 doi: 10.1111/jgh.16388
|
| 20 |
MA Amin, M Fawzi, D Sabri, H Sedrak, S Mausa. Liver Specific Serum Micro RNA122 as a Prognostic Marker in Egyptian Patients with Liver Cirrhosis. Archives of Hepatitis Research 2017; 3(1): 004 doi: 10.17352/ahr.000008
|
| 21 |
Gustavo Pereira, Caroline Baldin, Juliana Piedade, Vanessa Reis, Tatiana Valdeolivas, Lívia Victor, Lívia Guimarães, Joana Duarte, Zulane Veiga, Camila Alcântara, Flávia Fernandes, João Luiz Pereira. Combination and sequential evaluation of acute-on-chronic liver failure (ACLF) and hyponatremia and prognosis in cirrhotic patients. Digestive and Liver Disease 2020; 52(1): 91 doi: 10.1016/j.dld.2019.08.013
|
| 22 |
Piyush Mathur. Hepatorenal Syndrome-Current Concepts in Pathophysiology. Gastroenterology & Hepatology: Open Access 2017; 7(1) doi: 10.15406/ghoa.2017.07.00225
|
| 23 |
Zhaohui Bai, Le Wang, Hanyang Lin, Frank Tacke, Gang Cheng, Xingshun Qi. Use of Human Albumin Administration for the Prevention and Treatment of Hyponatremia in Patients with Liver Cirrhosis: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine 2022; 11(19): 5928 doi: 10.3390/jcm11195928
|
| 24 |
G. Marroncini, C. Anceschi, L. Naldi, B. Fibbi, M. Brogi, L. Lanzilao, A. Fanelli, M. Maggi, A. Peri. Hyponatremia-related liver steatofibrosis and impaired spermatogenesis: evidence from a mouse model of the syndrome of inappropriate antidiuresis. Journal of Endocrinological Investigation 2022; 46(5): 967 doi: 10.1007/s40618-022-01962-9
|
| 25 |
Alana Zulian Terres, Rafael Sartori Balbinot, Ana Laura Facco Muscope, Morgana Luisa Longen, Bruna Schena, Bruna Teston Cini, Gilberto Luis Rost, Juline Isabel Leichtweis Balensiefer, Louise Zanotto Eberhardt, Raul Angelo Balbinot, Silvana Sartori Balbinot, Jonathan Soldera. Evidence-based protocol for diagnosis and treatment of hepatorenal syndrome is independently associated with lower mortality. Gastroenterología y Hepatología (English Edition) 2022; 45(1): 25 doi: 10.1016/j.gastre.2021.02.009
|
| 26 |
Alana Zulian Terres, Rafael Sartori Balbinot, Ana Laura Facco Muscope, Morgana Luisa Longen, Bruna Schena, Bruna Teston Cini, Gilberto Luis Rost Jr, Juline Isabel Leichtweis Balensiefer, Louise Zanotto Eberhardt, Raul Angelo Balbinot, Silvana Sartori Balbinot, Jonathan Soldera. Acute-on-chronic liver failure is independently associated with higher mortality for cirrhotic patients with acute esophageal variceal hemorrhage: Retrospective cohort study. World Journal of Clinical Cases 2023; 11(17): 4003-4018 doi: 10.12998/wjcc.v11.i17.4003
Abstract(543) |
Core Tip(475) |
Full Article(HTML)(1326)
|
Full Article with Cover (PDF)-2343K(136)
|
Full Article (Word)-748K(31)
|
Audio-349K(17)
|
Peer-Review Report-139K(56)
|
Answering Reviewers-53K(57)
|
Full Article (PDF)-1047K(133)
|
Full Article (XML)-222K(50)
|
Times Cited (4)
|
Total Visits (5092)
|
Open
|
| 27 |
Alana Z. Terres, Rafael S. Balbinot, Ana L. F. Muscope, Louise Z. Eberhardt, Juline I. L. Balensiefer, Bruna T. Cini, Gilberto L. Rost, Morgana L. Longen, Bruna Schena, Raul A. Balbinot, Silvana S. Balbinot, Jonathan Soldera. Predicting mortality for cirrhotic patients with acute oesophageal variceal haemorrhage using liver‐specific scores. GastroHep 2021; 3(4): 236 doi: 10.1002/ygh2.460
|
| 28 |
Alana Zulian Terres, Rafael Sartori Balbinot, Ana Laura Facco Muscope, Morgana Luisa Longen, Bruna Schena, Bruna Teston Cini, Gilberto Luis Rost, Juline Isabel Leichtweis Balensiefer, Louise Zanotto Eberhardt, Raul Angelo Balbinot, Silvana Sartori Balbinot, Jonathan Soldera. Evidence-based protocol for diagnosis and treatment of hepatorenal syndrome is independently associated with lower mortality. Gastroenterología y Hepatología 2022; 45(1): 25 doi: 10.1016/j.gastrohep.2021.02.007
|